Cheviot Value Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.1M Buy
610,604
+54,772
+10% +$1.46M 1.72% 18
2025
Q4
$14.4M Buy
555,832
+59,656
+12% +$1.5M 1.41% 20
2025
Q3
$12.2M Buy
496,176
+1,277
+0.3% +$31.5K 1.29% 23
2025
Q2
$12.2M Sell
494,899
-3,841
-0.8% -$89.6K 1.39% 23
2025
Q1
$11.9M Buy
498,740
+58,118
+13% +$1.52M 1.46% 23
2024
Q4
$11.7M Buy
440,622
+24,562
+6% +$666K 2.24% 15
2024
Q3
$12M Sell
416,060
-11,479
-3% -$335K 2.27% 14
2024
Q2
$12M Buy
427,539
+22,112
+5% +$609K 2.34% 16
2024
Q1
$11.3M Buy
405,427
+79,833
+25% +$2.22M 2.47% 14
2023
Q4
$9.45M Buy
325,594
+19,843
+6% +$600K 2.03% 19
2023
Q3
$10.1M Buy
305,751
+10,452
+4% +$370K 2.24% 18
2023
Q2
$10.8M Buy
295,299
+24,460
+9% +$952K 2.36% 15
2023
Q1
$11.1M Buy
270,839
+5,345
+2% +$231K 2.66% 14
2022
Q4
$13.7M Sell
265,494
-2,530
-0.9% -$121K 3.38% 11
2022
Q3
$11.7M Buy
268,024
+1,753
+0.7% +$85.2K 3.2% 10
2022
Q2
$14M Sell
266,271
-2,738
-1% -$140K 3.48% 9
2022
Q1
$13.9M Buy
269,009
+17,331
+7% +$899K 2.95% 10
2021
Q4
$14.9M Sell
251,678
-1,890
-0.7% -$93.6K 3.48% 7
2021
Q3
$10.9M Buy
253,568
+4,479
+2% +$198K 2.8% 13
2021
Q2
$9.75M Buy
249,089
+6,008
+2% +$234K 2.39% 16
2021
Q1
$8.81M Buy
243,081
+24,443
+11% +$868K 2.45% 15
2020
Q4
$8.05M Sell
218,638
-5,920
-3% -$217K 2.43% 14
2020
Q3
$7.82M Buy
224,558
+6,493
+3% +$228K 2.71% 14
2020
Q2
$6.76M Buy
218,065
+7,774
+4% +$264K 2.64% 13
2020
Q1
$6.51M Sell
210,291
-3,773
-2% -$129K 2.97% 11
2019
Q4
$7.96M Buy
214,064
+401
+0.2% +$14.3K 3.07% 10
2019
Q3
$7.28M Buy
213,663
+432
+0.2% +$15.7K 3.1% 8
2019
Q2
$8.76M Sell
213,231
-8,726
-4% -$346K 3.79% 7
2019
Q1
$8.94M Sell
221,957
-1,572
-0.7% -$63K 4.35% 5
2018
Q4
$9.26M Sell
223,529
-9,035
-4% -$375K 4.82% 5
2018
Q3
$9.72M Sell
232,564
-6,745
-3% -$260K 4.57% 5
2018
Q2
$8.24M Sell
239,309
-6,765
-3% -$231K 4.04% 5
2018
Q1
$8.29M Buy
246,074
+2,196
+0.9% +$75.5K 4.31% 5
2017
Q4
$8.38M Buy
243,878
+974
+0.4% +$33.2K 4.34% 5
2017
Q3
$8.23M Buy
242,904
+5,425
+2% +$174K 4.47% 5
2017
Q2
$7.57M Buy
237,479
+5,866
+3% +$185K 4.41% 5
2017
Q1
$7.52M Buy
231,613
+7,620
+3% +$240K 4.23% 5
2016
Q4
$6.9M Buy
223,993
+1,334
+0.6% +$40.7K 4.13% 6
2016
Q3
$7.16M Sell
222,659
-2,978
-1% -$99.6K 4.44% 7
2016
Q2
$7.54M Buy
225,637
+89
+0% +$2.84K 4.5% 7
2016
Q1
$6.34M Buy
225,548
+12,312
+6% +$352K 4.05% 8
2015
Q4
$6.53M Sell
213,236
-595
-0.3% -$18.7K 4.23% 8
2015
Q3
$6.37M Sell
213,831
-1,280
-0.6% -$41K 4.24% 10
2015
Q2
$6.84M Buy
215,111
+735
+0.3% +$24K 4.04% 9
2015
Q1
$7.08M Sell
214,376
-787
-0.4% -$25K 4.17% 9
2014
Q4
$6.36M Buy
215,163
+553
+0.3% +$15.9K 3.7% 9
2014
Q3
$6.02M Buy
214,610
+6,598
+3% +$185K 3.49% 10
2014
Q2
$5.86M Sell
208,012
-4,704
-2% -$134K 3.13% 11
2014
Q1
$6.48M Sell
212,716
-10,250
-5% -$306K 3.58% 10
2013
Q4
$6.48M Sell
222,966
-4,627
-2% -$135K 3.58% 10
2013
Q3
$6.2M Sell
227,593
-4,496
-2% -$122K 3.42% 10
2013
Q2
$6.17M Buy
+232,089
New +$6.41M 3.37% 11

Other funds holding PFE

Cheviot Value Management's PFE Position: Q1 2026 in Review

Cheviot Value Management increased its Pfizer (PFE) stake by 9.9% in Q1 2026, buying an estimated $1.46M and bringing the position to 610,604 shares worth $17.1M. The position accounts for 1.72% of the portfolio, ranked #18.

Cheviot Value Management first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Cheviot Value Management held 610,604 shares of Pfizer worth $17.1M as of Q1 2026.
  • Cheviot Value Management bought 54,772 Pfizer shares in Q1 2026, an estimated $1.46M.
  • Pfizer made up 1.72% of Cheviot Value Management's portfolio in Q1 2026, its #18 holding.
  • Cheviot Value Management first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Cheviot Value Management's 13F filing for Q1 2026, filed 12 May 2026.